Angina Pectoris Drugs Global Market Report 2025

Global Angina Pectoris Drugs Market Report 2024

Angina Pectoris Drugs Global Market Report 2025 – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs), By Indication (Stable Angina, Unstable Angina, Prinzmetal’s Angina), By Route of Administration (Oral, Parenteral, Transdermal, Other Route Of Administrations), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Angina Pectoris Drugs Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Angina Pectoris Drugs Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Angina Pectoris Drugs Global Market Report 2025

Proud Members Of

Angina Pectoris Drugs Market Definition

Angina pectoris drugs are medications used to treat angina pectoris, a medical illness that causes chest pain or discomfort when a portion of the heart does not receive enough blood and oxygen. Angina pectoris drugs treat chest pain or discomfort due to coronary heart disease.

The main drugs of angina pectoris drugs are nitrates, antiplatelet agents, beta-adrenergic blocking agents, calcium channel blockers, anti-ischemic agents, statins, antihypertensive agents, and other drugs. Nitrates and nitrites are nitrogen and oxygen atom-containing chemicals. Nitrates are frequently used to treat angina pectoris, a condition that involves chest pain or discomfort caused by decreased blood supply to the heart. The indications include stable angina, unstable angina, and prinzmetal’s angina. The angina pectoris drugs are administered via oral, parenteral, transdermal, other route of administrations that are used by hospitals, homecare, specialty clinics, other end users.

Angina Pectoris Drugs Market Segmentation

The angina pectoris drugs market covered in this report is segmented –

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates

2) By Antiplatelet Agents: aspirin, clopidogrel

3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers

4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

5) By Anti-Ischemic Agents: Ranolazine, Ivabradine

6) By Statins: Atorvastatin, Rosuvastatin

Angina Pectoris Drugs Market Size and growth rate 2025 to 2029: Graph

Angina Pectoris Drugs Market Size 2025 And Growth Rate

The angina pectoris drugs market size has grown strongly in recent years. It will grow from$12.32 billion in 2024 to $12.94 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to the high prevalence of cardiovascular diseases, aging population demographics, lifestyle factors, increase in hypertension rates, and diabetes prevalence

Angina Pectoris Drugs Market Growth Forecast

The angina pectoris drugs market size is expected to see strong growth in the next few years. It will grow to $16.55 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising global obesity rates, advancements in precision medicine, focus on preventive cardiology, patient education initiatives, and research on novel therapeutic targets. Major trends in the forecast period include telemedicine for remote monitoring, real-world evidence and outcome studies, patient-centric medication education, strategic alliances for market access, regulatory advances, and expedited approvals.

Book your 30 minutes free consultation with our research experts

Angina Pectoris Drugs Market Driver: Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the angina pectoris drug market going forward. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including conditions like coronary artery disease, high blood pressure, heart failure, and stroke. The increasing prevalence of cardiovascular diseases (CVD) can be attributed to several factors, including an aging population, unhealthy lifestyles, and the obesity epidemic. Angina pectoris medications, such as nitrates, beta-blockers, and calcium channel blockers, effectively relieve chest pain and discomfort caused by insufficient blood flow to the heart, thereby enhancing patients' overall quality of life. For instance, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the angina pectoris drug market.

Angina Pectoris Drugs Market Driver: Soaring Rates Of Hypertension And Diabetes Propel Growth In The Angina Pectoris Drug Market

The increasing rates of hypertension and diabetes are expected to propel the growth of the angina pectoris drug market in the coming years. Hypertension, sometimes known as high blood pressure, is a medical disorder characterized by excessive arterial blood pressure. Diabetes is a long-term medical disorder marked by high blood glucose (sugar) levels. Diabetes and hypertension are prevalent risk factors for cardiovascular conditions, such as angina pectoris. The rising prevalence of these illnesses increases the demand for angina medicines. For instance, in June 2022, according to the World Health Organization, a Switzerland-based United Nations specialized organization in charge of global public health, By April 2022, about 2.5 million people with hypertension were recorded in over 15,000 healthcare facilities. Similarly, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based national agency, since last decade, the number of Australians with diabetes climbed by about 2.8 times, from 460,000 to 1.3 million. Therefore. The increasing rates of hypertension and diabetes are driving the angina pectoris drug market.

Global Angina Pectoris Drugs Market Major Players

Major companies operating in the angina pectoris drugs market include Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.

Global Angina Pectoris Drugs Market Trend: Hikma Pharmaceuticals Unveils Labetalol Hydrochloride Injection, Usp, Marking A Milestone In Angina Pectoris Drug Market

Product innovation is a key trend gaining popularity in angina pectoris drugs market. Major companies operating in the angina pectoris drug market are adopting new technologies to sustain their position in the market. For instance, in March 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Labetalol Hydrochloride Injection, USP, in a prefilled syringe. The Food and Drug Administration of the United States has authorized this product. In hospitals, 10 mg/2 mL PFS is used to treat severe hypertension and lower blood pressure.

Global Angina Pectoris Drugs Market Trend: Zydus Lifesciences Secures FDA Approval For Nitrostat, Enhancing Angina Pectoris Drug Market Offerings

Major companies operating in the angina pectoris drug market are focusing on approvals for innovative products, such as the U.S. Food and Drug Administration's approval of Nitrostat (Nitroglycerin Sublingual Tablets) for treating angina and to better meet the needs of their existing consumers. Nitrostat (Nitroglycerin Sublingual Tablets) has been authorized by the United States Food and Drug Administration (FDA) for the immediate treatment of angina pectoris or the acute prevention of angina pectoris. For instance, in March 2022, Zydus Lifesciences Ltd., an India-based pharmaceutical company, announced that Nitrostat had been approved by the U.S. Food and Drug Administration to sell 0.3 mg, 0.4 mg, and 0.6 mg Nitrophlycerin sublingual tablets. Nitroglycerin sublingual tablets are prescribed to patients with coronary artery disease (CAD) to treat angina or chest discomfort. It can also be taken before exercise to assist in avoiding chest soreness. Nitroglycerin is a member of the nitrate pharmacological class. This medication widens and relaxes blood vessels, facilitating easier blood flow to the heart.

Angina Pectoris Drugs Market Merger And Acquisition: Alcon Strengthens Portfolio With Strategic Acquisition Of Aerie Pharmaceuticals Inc., Expanding Presence In Angina Pectoris Drug Market

In November 2022, Alcon, a US-based pharmaceutical and medical device company, acquired Aerie Pharmaceuticals Inc. for an undisclosed amount. This acquisition broadens, diversifies, and enriches Alcon's portfolio of commercial products and development pipeline, with a strong position in the ophthalmic pharmaceutical industry. Aerie Pharmaceuticals Inc. is a US-based clinical-stage pharmaceutical company offering the angina pectoris drug.

Regional Analysis For The Global Angina Pectoris Drugs Market

North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the angina pectoris drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Angina Pectoris Drugs Market?

The angina pectoris drugs market consists of sales of aspirin, ranolazine, and angiotensin-converting enzyme inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Angina Pectoris Drugs Industry?

The angina pectoris drugs market research report is one of a series of new reports from The Business Research Company that provides angina pectoris drugs market statistics, including angina pectoris drugs industry global market size, regional shares, competitors with an angina pectoris drugs market share, detailed angina pectoris drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the angina pectoris drugs industry. This angina pectoris drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Angina Pectoris Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$12.94 billion
Revenue Forecast In 2034	$16.55 billion
Growth Rate	CAGR of 6.3% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs 2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina 3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations 4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates 2) By Antiplatelet Agents: Aspirin, Clopidogrel 3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers 4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers 5) By Anti-Ischemic Agents: Ranolazine, Ivabradine 6) By Statins: Atorvastatin, Rosuvastatin
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Angina Pectoris Drugs Market Characteristics

3. Angina Pectoris Drugs Market Trends And Strategies

4. Angina Pectoris Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Angina Pectoris Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Angina Pectoris Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Angina Pectoris Drugs Market Growth Rate Analysis

5.4. Global Angina Pectoris Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Angina Pectoris Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Angina Pectoris Drugs Total Addressable Market (TAM)

6. Angina Pectoris Drugs Market Segmentation

6.1. Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nitrates

Antiplatelet Agents

Beta-adrenergic Blocking Agents

Calcium Channel Blockers

Anti-ischemic Agents

Statins

Antihypertensive Agents

6.2. Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stable Angina

Unstable Angina

Prinzmetal’s Angina

6.3. Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Transdermal

Other Route Of Administrations

6.4. Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.5. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Short-Acting Nitrates

Long-Acting Nitrates

6.6. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aspirin

Clopidogrel

6.7. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Selective Beta Blockers

Selective Beta Blockers

6.8. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dihydropyridine Calcium Channel Blockers

Non-dihydropyridine Calcium Channel Blockers

6.9. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ranolazine

Ivabradine

6.10. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atorvastatin

Rosuvastatin

7. Angina Pectoris Drugs Market Regional And Country Analysis

7.1. Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Angina Pectoris Drugs Market

8.1. Asia-Pacific Angina Pectoris Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Angina Pectoris Drugs Market

9.1. China Angina Pectoris Drugs Market Overview

9.2. China Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Angina Pectoris Drugs Market

10.1. India Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Angina Pectoris Drugs Market

11.1. Japan Angina Pectoris Drugs Market Overview

11.2. Japan Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Angina Pectoris Drugs Market

12.1. Australia Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Angina Pectoris Drugs Market

13.1. Indonesia Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Angina Pectoris Drugs Market

14.1. South Korea Angina Pectoris Drugs Market Overview

14.2. South Korea Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Angina Pectoris Drugs Market

15.1. Western Europe Angina Pectoris Drugs Market Overview

15.2. Western Europe Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Angina Pectoris Drugs Market

16.1. UK Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Angina Pectoris Drugs Market

17.1. Germany Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Angina Pectoris Drugs Market

18.1. France Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Angina Pectoris Drugs Market

19.1. Italy Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Angina Pectoris Drugs Market

20.1. Spain Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Angina Pectoris Drugs Market

21.1. Eastern Europe Angina Pectoris Drugs Market Overview

21.2. Eastern Europe Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Angina Pectoris Drugs Market

22.1. Russia Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Angina Pectoris Drugs Market

23.1. North America Angina Pectoris Drugs Market Overview

23.2. North America Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Angina Pectoris Drugs Market

24.1. USA Angina Pectoris Drugs Market Overview

24.2. USA Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Angina Pectoris Drugs Market

25.1. Canada Angina Pectoris Drugs Market Overview

25.2. Canada Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Angina Pectoris Drugs Market

26.1. South America Angina Pectoris Drugs Market Overview

26.2. South America Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Angina Pectoris Drugs Market

27.1. Brazil Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Angina Pectoris Drugs Market

28.1. Middle East Angina Pectoris Drugs Market Overview

28.2. Middle East Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Angina Pectoris Drugs Market

29.1. Africa Angina Pectoris Drugs Market Overview

29.2. Africa Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Angina Pectoris Drugs Market Competitive Landscape And Company Profiles

30.1. Angina Pectoris Drugs Market Competitive Landscape

30.2. Angina Pectoris Drugs Market Company Profiles

30.2.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Angina Pectoris Drugs Market Other Major And Innovative Companies

31.1. Merck & Co Inc.

31.2. Eli Lilly and Company

31.3. Pfizer Inc.

31.4. Abbott Laboratories

31.5. Sun Pharmaceutical Industries Limited

31.6. Sanofi SA

31.7. Boehringer Ingelheim International GmbH

31.8. Bristol-Myers Squibb Company

31.9. Johnson & Johnson

31.10. AERIE PHARMACEUTICALS INC.

31.11. AbbVie Inc.

31.12. Amgen Inc.

31.13. Gilead Sciences Inc.

31.14. GlaxoSmithKline plc

31.15. H. Lundbeck A/S

32. Global Angina Pectoris Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Angina Pectoris Drugs Market

34. Recent Developments In The Angina Pectoris Drugs Market

35. Angina Pectoris Drugs Market High Potential Countries, Segments and Strategies

35.1 Angina Pectoris Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Angina Pectoris Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Angina Pectoris Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Astellas Pharma Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Novartis AG Financial Performance

Table 84: AstraZeneca PLC Financial Performance

Table 85: Bausch Health Companies Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Astellas Pharma Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Novartis AG Financial Performance

Figure 84: AstraZeneca PLC Financial Performance

Figure 85: Bausch Health Companies Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oncology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Muscle Relaxant Drugs Global Market Report 2025 – By Drug Type( Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Formulation( Cyclobenzaprine, Carisoprodol, Chlorzoxazone, Metaxalone, Methocarbamol, Baclofen, Tizanidine, Orphenadrine, Dantrolene ), By Route of Administration( Oral, Injectable, Spray, Ointment), By End-User( Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Alzheimer's Drugs Global Market Report 2025 – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early To Moderate Stages, Moderate To Severe Stages) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Osteoporosis Drugs Global Market Report 2025 – By Type (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors), By Administration (Oral, Injectable), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Sales), By Application (Primary Osteoporosis, Secondary Osteoporosis) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Generic Central Nervous System Drugs Global Market Report 2025 – By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other Types), By Drug Classification (Branded Drugs, Generic Drugs), By Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation, Other Route Of Administrations), By Mode Of Purchase (Over-the-counter drugs, Prescription-Based Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Quit Smoking Drugs Global Market Report 2025 – By Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets), By Drug (Varenicline (Chantix), Bupropion (Zyban), Other Drugs), By Distribution (Drug Store, Online Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biologic & Biosimilar RA Drugs Global Market Report 2025 – By Source (Microbial, Mammalian, Other Sources), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Other Diseases), By Manufacturing (Outsourced, In-House), By Mode Of Purchase (Prescription Drugs, Over-The-Counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drugs of Abuse (DOA) Testing Global Market Report 2025 – By Product And Service (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), By Sample Type (Urine, Hair, Oral Fluid, Breath), By Application (Pain Management, Criminal Justice, Workplace Screening), By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Angina Pectoris Drugs market?

How will the Angina Pectoris Drugs market drivers and restraints affect the market dynamics? What forces will shape the Angina Pectoris Drugs industry going forward?

The Angina Pectoris Drugs market major growth driver - Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market. For further insights on the Angina Pectoris Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Angina Pectoris Drugs market?

The Angina Pectoris Drugs market size has grown strongly in recent years. The angina pectoris drugs market size has grown strongly in recent years. It will grow from$12.32 billion in 2024 to $12.94 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to the high prevalence of cardiovascular diseases, aging population demographics, lifestyle factors, increase in hypertension rates, and diabetes prevalence The angina pectoris drugs market size is expected to see strong growth in the next few years. It will grow to $16.55 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising global obesity rates, advancements in precision medicine, focus on preventive cardiology, patient education initiatives, and research on novel therapeutic targets. Major trends in the forecast period include telemedicine for remote monitoring, real-world evidence and outcome studies, patient-centric medication education, strategic alliances for market access, regulatory advances, and expedited approvals. For further insights on the Angina Pectoris Drugs market, request a sample here

How is the Angina Pectoris Drugs market segmented?

The angina pectoris drugs market covered in this report is segmented –
1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina
3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments:
1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates
2) By Antiplatelet Agents: Aspirin, Clopidogrel
3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers
4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers
5) By Anti-Ischemic Agents: Ranolazine, Ivabradine
6) By Statins: Atorvastatin, Rosuvastatin For further insights on the Angina Pectoris Drugs market, request a sample here

Which region has the largest share of the Angina Pectoris Drugs market? What are the other regions covered in the report?

North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Angina Pectoris Drugs market, request a sample here.

Who are the major players in the Angina Pectoris Drugs market?

What are the key trends in the Angina Pectoris Drugs market?

Major trends in the Angina Pectoris Drugs market include Hikma Pharmaceuticals Unveils Labetalol Hydrochloride Injection, Usp, Marking A Milestone In Angina Pectoris Drug Market. For further insights on the Angina Pectoris Drugs market, request a sample here.

What are the major opportunities in the Angina Pectoris Drugs market? What are the strategies for the Angina Pectoris Drugs market?

For detailed insights on the major opportunities and strategies in the Angina Pectoris Drugs market, request a sample here.

How does the Angina Pectoris Drugs market relate to the overall economy and other similar markets?

For detailed insights on Angina Pectoris Drugs's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Angina Pectoris Drugs industry?

For detailed insights on the mergers and acquisitions in the Angina Pectoris Drugs industry, request a sample here.

What are the key dynamics influencing the Angina Pectoris Drugs market growth? SWOT analysis of the Angina Pectoris Drugs market.

For detailed insights on the key dynamics influencing the Angina Pectoris Drugs market growth and SWOT analysis of the Angina Pectoris Drugs industry, request a sample here.